2. Search Result
Search Result
Results for "

tocolytic agent

" in MedChemExpress (MCE) Product Catalog:

9

Inhibitors & Agonists

1

Biochemical Assay Reagents

4

Peptides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-W587861
    5β-Dihydroprogesterone
    1 Publications Verification

    5βDHP

    		 Oxytocin Receptor Endocrinology
    5β-Dihydroprogesterone (5βDHP) is the metabolite of Progesterone (HY-N0437). 5β-Dihydroprogesterone binds to oxytocin receptor, reduces the Oxytocin (HY-17571)-induced calcium signal transduction, thereby exhibiting the tocolytic activity .
    5β-Dihydroprogesterone
  • HY-17572
    Atosiban
    4 Publications Verification

    RW22164; RWJ22164

    		 Oxytocin Receptor Vasopressin Receptor Cardiovascular Disease Endocrinology Cancer
    Atosiban (RW22164; RWJ22164) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research .
    Atosiban
  • HY-17572A
    Atosiban acetate
    4 Publications Verification

    RW22164 acetate; RWJ22164 acetate

    		 Oxytocin Receptor Vasopressin Receptor Cardiovascular Disease Endocrinology Cancer
    Atosiban acetate (RW22164 acetate;RWJ22164 acetate) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research .
    Atosiban acetate
  • HY-108677
    L-368,899 hydrochloride
    4 Publications Verification

    		 Oxytocin Receptor Endocrinology
    L-368,899 hydrochloride is a potent, selective, orally bioavailable, non-peptide oxytocin receptor antagonist, with IC50s of 8.9 nM and 26 nM for rat uterus and human uterus oxytocin receptor, respectively. L-368,899 hydrochloride used as a tocolytic agent .
    L-368,899 hydrochloride
  • HY-W094475D
    Magnesium sulfate heptahydrate, meets analytical specification of Ph. Eur. BP USP FCC

    Epsom salts, meets analytical specification of Ph. Eur. BP USP FCC

    		 Biochemical Assay Reagents Cardiovascular Disease Cancer
    Magnesium sulfate heptahydrate, meets analytical specification of Ph. Eur. BP USP FCC is currently the anticonvulsant of choice for the prevention and control of eclamptic fits. Magnesium sulfate is also widely used as a tocolytic agent .
    Magnesium sulfate heptahydrate, meets analytical specification of Ph. Eur. BP USP FCC
  • HY-17572R
    Atosiban (Standard)

    RW22164 (Standard); RWJ22164 (Standard)

    		 Reference Standards Oxytocin Receptor Vasopressin Receptor Endocrinology Cancer
    Atosiban (Standard) is the analytical standard of Atosiban. This product is intended for research and analytical applications. Atosiban (RW22164; RWJ22164) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research .
    Atosiban (Standard)
  • HY-17572AR
    Atosiban acetate (Standard)

    RW22164 acetate (Standard); RWJ22164 acetate (Standard)

    		 Reference Standards Oxytocin Receptor Vasopressin Receptor Endocrinology Cancer
    Atosiban (acetate) (Standard) is the analytical standard of Atosiban (acetate). This product is intended for research and analytical applications. Atosiban acetate (RW22164 acetate;RWJ22164 acetate) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research .
    Atosiban acetate (Standard)
  • HY-15018A
    SSR126768A free base

    		Oxytocin Receptor Endocrinology
    SSR126768A free base is an orally active antagonist for oxytocin receptor, with Ki of 0.44 nM. SSR126768A free base is a tocolytic agent, that antagonizes the Oxytocin (HY-17571)-induced intracellular Ca 2+ increase and prostaglandin release in human uterine smooth muscle cells, inhibits thus the Oxytocin (HY-17571)-induced uterine contraction and delays parturition in pregnant rats in labor .
    SSR126768A free base
  • HY-15007
    L 366509

    		Oxytocin Receptor Endocrinology
    L 366509 is a spiroindenylpiperidine camphorsulfonamide oxytocin (OT) antagonist. Modifications led to a new series of o-tolylpiperazine (TP) camphorsulfonamides, exhibiting high affinity for OT receptors and selectivity over arginine vasopressin receptors. Notably, compound 7 (L-368,899) showed excellent OT receptor affinity, potency in inhibiting OT-stimulated uterine contractions, good aqueous solubility, and oral bioavailability in multiple species. Compound 7 has entered clinical testing as an oral and intravenous tocolytic agent. Molecular modeling suggests the TP camphorsulfonamide structure mimics the D-AA2-Ile3 dipeptide, crucial in potent OT antagonists .
    L 366509

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: